Since fibrate drugs such as gemfibrozil are ligands for PPARα, the reduced expression of PPARα in T cells of sarcoidosis patients without LS may suggest that this class of drugs may also become candidate for treatment of sarcoidosis. This evidence concerns the gene PPARA and Leigh syndrome.